Reidun Aesoy Selected Research

myxin

4/2021	New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells.
1/2017	Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reidun Aesoy Research Topics

Disease

4	Neoplasms (Cancer) 10/2021 - 10/2008
3	Hypoxia (Hypoxemia) 04/2021 - 03/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2015 - 10/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Leukemia 01/2017
1	Carcinogenesis 03/2014

Drug/Important Bio-Agent (IBA)

2	OxidesIBA 04/2021 - 01/2017
2	iodininIBA 04/2021 - 01/2017
2	myxinIBA 04/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2014
1	Peptides (Polypeptides)IBA 10/2021
1	ProdrugsIBA 04/2021
1	phenazine di-N-oxideIBA 04/2021
1	Phosphotransferases (Kinase)IBA 01/2019
1	CytochromesIBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2017
1	Orphan Nuclear ReceptorsIBA 01/2015
1	Messenger RNA (mRNA)IBA 03/2014
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 03/2014
1	Estrogen Receptor AntagonistsIBA 10/2008
1	Tamoxifen FDA LinkGeneric 10/2008
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 10/2008
1	afimoxifene (hydroxytamoxifen)IBA 10/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2008
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2008
1	p38 Mitogen-Activated Protein KinasesIBA 10/2008

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2019